- Review
Targeting NLRP3-Mediated Neuroinflammation in Alzheimer’s Disease Treatment
- Julia Barczuk,
- Natalia Siwecka,
- Weronika Lusa,
- Wioletta Rozpędek-Kamińska,
- Ewa Kucharska and
- Ireneusz Majsterek
Alzheimer’s disease (AD) is the most common cause of dementia in the general population and, to date, constitutes a major therapeutic challenge. In the pathogenesis of AD, aggregates of amyloid β (Aβ) and neurofibrillary tangles (NFTs...